The role of genetic risk factors of Alzheimer's disease in synaptic dysfunction

被引:19
|
作者
Fu, Wing-Yu [1 ,2 ]
Ip, Nancy Y. [1 ,2 ,3 ]
机构
[1] Hong Kong Univ Sci & Technol, Mol Neurosci Ctr, Div Life Sci, State Key Lab Mol Neurosci,Clear Water Bay,Kowloon, Hong Kong, Peoples R China
[2] Hong Kong Ctr Neurodegenerat Dis, Hong Kong Sci Pk, Hong Kong, Peoples R China
[3] Shenzhen Hong Kong Inst Brain Sci, HKUST Shenzhen Res Inst, Guangdong Prov Key Lab Brain Sci Dis & Drug Dev, Shenzhen 518057, Guangdong, Peoples R China
关键词
Synapses; Genetic risks; Synaptic vesicles; Neurotransmitter release; Neurotransmission; Synaptic plasticity; Protein trafficking; GENOME-WIDE ASSOCIATION; APOE GENOTYPE; RECEPTOR FUNCTION; PROTEIN CD2AP; PLASTICITY; ADAM10; TREM2; BETA; PHOSPHORYLATION; MUTATIONS;
D O I
10.1016/j.semcdb.2022.07.011
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Alzheimer's disease (AD) is a neurodegenerative disease characterized by the progressive deterioration of cognitive functions. Due to the extended global life expectancy, the prevalence of AD is increasing among aging populations worldwide. While AD is a multifactorial disease, synaptic dysfunction is one of the major neuro-pathological changes that occur early in AD, before clinical symptoms appear, and is associated with the pro-gression of cognitive deterioration. However, the underlying pathological mechanisms leading to this synaptic dysfunction remains unclear. Recent large-scale genomic analyses have identified more than 40 genetic risk factors that are associated with AD. In this review, we discuss the functional roles of these genes in synapto-genesis and synaptic functions under physiological conditions, and how their functions are dysregulated in AD. This will provide insights into the contributions of these encoded proteins to synaptic dysfunction during AD pathogenesis.
引用
收藏
页码:3 / 12
页数:10
相关论文
共 50 条
  • [1] Key Role of Mitochondria in Alzheimer's Disease Synaptic Dysfunction
    Cavallucci, Virve
    Ferraina, Caterina
    D'Amelio, Marcello
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (36) : 6440 - 6450
  • [2] Intracellular Trafficking Mechanisms of Synaptic Dysfunction in Alzheimer's Disease
    Perdigao, Catarina
    Barata, Mariana A.
    Araujo, Margarida N.
    Mirfakhar, Farzaneh S.
    Castanheira, Jorge
    Guimas Almeida, Claudia
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2020, 14
  • [3] Synaptic dysfunction in genetic models of Parkinson's disease: A role for autophagy?
    Plowey, Edward D.
    Chu, Charleen T.
    NEUROBIOLOGY OF DISEASE, 2011, 43 (01) : 60 - 67
  • [4] Role of Aβ in Alzheimer's-related synaptic dysfunction
    Zhang, Huiqin
    Jiang, Xuefan
    Ma, Lina
    Wei, Wei
    Li, Zehui
    Chang, Surui
    Wen, Jiayu
    Sun, Jiahui
    Li, Hao
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [5] Synaptic dysfunction in Parkinson's disease
    Bagetta, Vincenza
    Ghiglieri, Veronica
    Sgobio, Carmelo
    Calabresi, Paolo
    Picconi, Barbara
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2010, 38 : 493 - 497
  • [6] Circuitry and Synaptic Dysfunction in Alzheimer's Disease: A New Tau Hypothesis
    Mondragon-Rodriguez, Siddhartha
    Salgado-Burgos, Humberto
    Pena-Ortega, Fernando
    NEURAL PLASTICITY, 2020, 2020
  • [7] Oxidative Stress, Synaptic Dysfunction, and Alzheimer's Disease
    Tonnies, Eric
    Trushina, Eugenia
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 57 (04) : 1105 - 1121
  • [8] Targeting Synaptic Dysfunction in Alzheimer's Disease Therapy
    Nistico, Robert
    Pignatelli, Marco
    Piccinin, Sonia
    Mercuri, Nicola B.
    Collingridge, Graham
    MOLECULAR NEUROBIOLOGY, 2012, 46 (03) : 572 - 587
  • [9] Alzheimer's disease, amyloid peptide and synaptic dysfunction
    Hemar, Agnes
    Mulle, Christophe
    M S-MEDECINE SCIENCES, 2011, 27 (8-9): : 733 - 736
  • [10] Targeting Synaptic Dysfunction in Alzheimer’s Disease Therapy
    Robert Nisticò
    Marco Pignatelli
    Sonia Piccinin
    Nicola B. Mercuri
    Graham Collingridge
    Molecular Neurobiology, 2012, 46 : 572 - 587